Workshop on Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework, 40862 [2021-16118]

Download as PDF 40862 Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: July 23, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–16160 Filed 7–28–21; 8:45 am] https://www.nichd.nih.gov/about/ meetings/2021/092321. Alison N. Cernich, Deputy Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. [FR Doc. 2021–16118 Filed 7–28–21; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Workshop on Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework National Institutes of Health, Health and Human Services (HHS). ACTION: Notice. AGENCY: This 2-day, virtual workshop—Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework—focuses on the functional state-of-the-science of biologically active human milk components and analogs and the implications for safety assessments when used in infant formula. SUMMARY: The Meeting will be held on September 23–24, 2021, from 10:30 a.m. to 4:30 p.m. (ET). ADDRESSES: This workshop will be videocast at https://videocast.nih.gov. FOR FURTHER INFORMATION CONTACT: For information concerning this meeting, contract Dr. Ashley Vargas, Pediatric Growth and Nutrition Branch, Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6701B Rockledge Drive, Room 2423C, Bethesda, MD 20817, telephone: 301– 827–6030, email: ashley.vargas@ nih.gov. DATES: This Federal Register notice is in accordance with 42 U.S.C. 285g, of the Public Health Service Act, as amended. This workshop is led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institutes of Health (NIH) Office of Dietary Supplements (ODS), and the Food and Drug Administration (FDA). The workshop is free and open to the public. The workshop will be livestreamed, and the video will be archived. Registration will be available for this meeting at jbell on DSKJLSW7X2PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 19:19 Jul 28, 2021 Jkt 253001 National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; IMAT Biospecimen Research. Date: September 30, 2021. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850, 240–276–5460, jfang@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–2: NCI Clinical and Translational Cancer Research. Date: October 20–21, 2021. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850, 240–276–7286, salvucco@ mail.nih.gov. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Name of Committee: National Cancer Institute Initial Review Group; Transition to Independence Study Section (I). Date: October 20–21, 2021. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W602, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Delia Tang, M.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W602, Rockville, Maryland 20850, 240–276–6456, tangd@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–3: NCI Clinical and Translational Cancer Research. Date: October 21–22, 2021. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Shuli Xia, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850, shuli.xia@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–8: NCI Clinical and Translational Cancer Research. Date: November 4–5, 2021. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W126, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Susan Lynn Spence, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Rockville, Maryland 20850, susan.spence@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–4: NCI Clinical and Translational Cancer Research. Date: November 4–5, 2021. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850, 240–276–7975, chufanee@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; E:\FR\FM\29JYN1.SGM 29JYN1

Agencies

[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Page 40862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16118]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Workshop on Exploring the Science Surrounding the Safe Use of 
Bioactive Ingredients in Infant Formula: Considerations for an 
Assessment Framework

AGENCY: National Institutes of Health, Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This 2-day, virtual workshop--Exploring the Science 
Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: 
Considerations for an Assessment Framework--focuses on the functional 
state-of-the-science of biologically active human milk components and 
analogs and the implications for safety assessments when used in infant 
formula.

DATES: The Meeting will be held on September 23-24, 2021, from 10:30 
a.m. to 4:30 p.m. (ET).

ADDRESSES: This workshop will be videocast at https://videocast.nih.gov.

FOR FURTHER INFORMATION CONTACT: For information concerning this 
meeting, contract Dr. Ashley Vargas, Pediatric Growth and Nutrition 
Branch, Division of Extramural Research, Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, 6701B 
Rockledge Drive, Room 2423C, Bethesda, MD 20817, telephone: 301-827-
6030, email: [email protected].

SUPPLEMENTARY INFORMATION: This Federal Register notice is in 
accordance with 42 U.S.C. 285g, of the Public Health Service Act, as 
amended. This workshop is led by the Eunice Kennedy Shriver National 
Institute of Child Health and Human Development (NICHD), the National 
Institutes of Health (NIH) Office of Dietary Supplements (ODS), and the 
Food and Drug Administration (FDA). The workshop is free and open to 
the public. The workshop will be livestreamed, and the video will be 
archived. Registration will be available for this meeting at https://www.nichd.nih.gov/about/meetings/2021/092321.

Alison N. Cernich,
Deputy Director, Eunice Kennedy Shriver National Institute of Child 
Health and Human Development, National Institutes of Health.
[FR Doc. 2021-16118 Filed 7-28-21; 8:45 am]
BILLING CODE 4140-01-P